news
HPAPI market to value $27bn by 2025
Driven by oncology drug demand, the highly potent active pharmaceutical ingredients (HPAPIs) market is anticipated to grow by $7bn in three years.
List view / Grid view
BASF
article
Excipients in drug formulations
Excipients are integral components of pharmaceutical drug products. Their demand is expected to increase over the next five years owing to their ability to perform various functions such as improving active pharmaceutical ingredient (API) stability, modifying drug release and taste masking. Here, Prateeksha Kaul explores the factors and trends that…
news
BASF to enter medical foods market in the US with DIEM Labs
BASF Corporation and DIEM Labs, LLC. have entered into a distribution agreement to commercialize BASF’s first U.S. medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD)...
news
BASF completes acquisition of Pronova BioPharma
31 January 2013 | By BASF
BASF has completed the acquisition of Pronova BioPharma ASA, Lysaker, Norway...
news
New head of BASF unit Pharma Ingredients & Services
1 October 2012 | By BASF
As of October 1, Scott Thomson will assume the role of Senior Vice President...
news
BASF showcases expertise at CPhI worldwide in Madrid, Spain
17 September 2012 | By BASF
Visit us at CPhI worldwide Oct. 9-11, 2012 Hall 4, Booth 4D17 Feria de Madrid, Spain...
news
Pharma Japan 2012: BASF presents its comprehensive and intelligent pharmaceutical solutions
27 June 2012 | By BASF
BASF showcases its comprehensive solution profile with solid expertise...
news
BASF subsidiary Metanomics Health launches MetaMap®Tox
6 June 2012 | By BASF
Metanomics Health GmbH is launching MetaMap®Tox...
news
BASF acquires global leader in omega-3 fatty acids for the pharmaceutical industry
9 May 2012 | By BASF
BASF has announced the acquisition of Equateq Ltd...
news
BASF relocates production of Kolliphor TPGS to its Minden site
30 April 2012 | By
BASF will transfer the pharmaceutical production of KolliphorTM TPGS to its Minden facility...
news
BASF introduces extended solubilization and dermatology excipients portfolios
12 April 2012 | By BASF
After acquiring Cognis in 2011, BASF has significantly expanded its range of solubilization and dermatology excipients...
news
BASF and Catalent join forces to solve bioavailability challenges
4 April 2012 | By Catalent Pharma Solutions
Catalent Pharma Solutions and BASF have entered into a broad collaboration...
news
BASF aligns research even more closely to future topics, global markets and customer industries
29 March 2012 | By BASF
BASF is setting itself ambitious goals...
